BioSpace News Archive

Press Releases

Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer

July 25, 2025
·
8 min read
Press Releases

Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference

July 25, 2025
·
1 min read
Press Releases

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

July 25, 2025
·
1 min read
Press Releases

Abivax announces trading resumption of its ordinary shares on Euronext Paris

July 25, 2025
·
1 min read
Press Releases

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

July 25, 2025
·
10 min read
Press Releases

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus

July 25, 2025
·
5 min read
Press Releases

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

July 25, 2025
·
6 min read
Press Releases

Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update

July 25, 2025
·
5 min read
Press Releases

Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases

July 25, 2025
·
2 min read
Press Releases

Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results

July 25, 2025
·
1 min read